- Home
- AGNCM vs SNN Comparison
AGNCM vs SNN Comparison
Compare AGNCM & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
AGNCM
AGNC Investment Corp. Depositary Shares rep 6.875% Series D Fixed-to-Floating Cumulative Redeemable Preferred Stock
Current Price
Current Price
Company Overview
Basic Information| Metric | AGNCM | SNN |
|---|---|---|
| Founded | 2008 | 1856 |
| Country | United States | United Kingdom |
| Employees | 54 | N/A |
| Industry | Real Estate Investment Trusts | Industrial Specialties |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | 14.3B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | AGNCM | SNN |
|---|---|---|
| Price | $24.50 | $31.68 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $36.25 |
| AVG Volume (30 Days) | 15.3K | ★ 790.5K |
| Earning Date | 01-26-2026 | 03-02-2026 |
| Dividend Yield | ★ 9.05% | 2.33% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $13.57 | $7.19 |
| Revenue Next Year | $60.72 | $5.36 |
| P/E Ratio | ★ $17.72 | $64.97 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $23.01 | $23.91 |
| 52 Week High | $25.47 | $38.79 |
Technical Indicators
Market Signals| Indicator | AGNCM | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 35.33 | 32.93 |
| Support Level | $23.97 | $29.27 |
| Resistance Level | $25.27 | $33.89 |
| Average True Range (ATR) | 0.15 | 0.53 |
| MACD | -0.03 | -0.15 |
| Stochastic Oscillator | 15.25 | 0.90 |
Price Performance
Historical ComparisonAbout AGNCM AGNC Investment Corp. Depositary Shares rep 6.875% Series D Fixed-to-Floating Cumulative Redeemable Preferred Stock
AGNC Investment Corp is a real estate investment trust that invests in agency residential mortgage-backed securities. The firm's asset portfolio is comprised of residential mortgage pass-through securities and collateralized mortgage obligations for which the principal and interest payments are guaranteed by a U.S. Government-sponsored enterprise, such as the Federal National Mortgage Association and the Federal Home Loan Mortgage Corporation, or by a U.S. Government agency, such as the Government National Mortgage Association. It also invests in other types of mortgage and mortgage-related residential and commercial mortgage-backed securities or other investments in or related to, the housing, mortgage, or real estate markets.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.